mouse fgf23 elisa kit Search Results


mouse fibroblast growth factor 23 (fgf23) elisa kit  (Bioss)
N/A
   Buy from Supplier
mouse phosphatonin (fgf23) elisa kit  (Innovative Research Inc)
N/A
This Mouse Phosphatonin (FGF23) ELISA Kit from Innovative Research is intended for quantitative detection of mouse FGF23 in cell culture supernates, cell lysates, serum and plasma (heparin, EDTA). Strip well format. Reagents for up to
   Buy from Supplier
mouse fgf23 elisa kit  (Cusabio)
91
Cusabio mouse fgf23 elisa kit
Transcriptomic analysis of femoral tissues from sham, OVX, and OVX + GLP-2 groups. A Scatter plot of DEGs between the OVX and sham groups (1654 upregulated genes and 2038 downregulated genes). B Scatter plot of DEGs between the OVX + GLP-2 and OVX groups (318 upregulated genes and 396 downregulated genes). C Heatmap of 24 representative DEGs among the three groups. D GO enrichmentresults showing DEGs involved in cellular component, biological process, and molecular function categories. E KEGG signalling pathway diagram. F KEGG enrichment bar chart. G KEGG enrichment scatter plot. H Relative mRNA expression of <t>FGF23,</t> FGF6, and FGF18 in the tibiae of the OVX group
Mouse Fgf23 Elisa Kit, supplied by Cusabio, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+fgf23+elisa+kit/Mouse+Fibroblast+growth+factor+23(FGF23)+ELISA+kit/pmc12874791-100-10-15
Average 91 stars, based on 1 article reviews
mouse fgf23 elisa kit - by Bioz Stars, 2026-09
91/100 stars
  Buy from Supplier
mouse fgf23 elisa kit  (Elabscience Biotechnology)
93
Elabscience Biotechnology mouse fgf23 elisa kit
Figure 1. Fucoidan Treatment Reversed the Changes of Serum Biochemical Indexes Caused by the Modeling. A–D, the Levels of BUN, Creatinine, ALP, and Pi in the Serum of Mice in the Five Groups were Detected by an Automatic Biochemical Analyzer. E–G, the Levels of iPTH, <t>FGF23,</t> and 1,25 (OH)2D3 in the Serum of Mice in the Five Groups Were Determined by ELISA. H, the Relative BMD of Mice in the Five Groups Was Measured by X-Ray Densitometers.
Mouse Fgf23 Elisa Kit, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+fgf23+elisa+kit/Mouse+FGF23+(Fibroblast+Growth+Factor+23)+ELISA+Kit/10__1177_slash_09731296231172549-58-35-40
Average 93 stars, based on 1 article reviews
mouse fgf23 elisa kit - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier
elisa kit fgf23 mouse  (G Biosciences)
N/A
An ELISA kit for the detection of Fgf23 Mouse This uses Sandwich ELISA Double Antibody and has a sensitivity of 9 375pg ml
   Buy from Supplier
mouse fgf23 elisa kit  (Rockland Immunochemicals)
N/A
Mouse FGF23 AccuSignal ELISA Kit - KOA0823
   Buy from Supplier
mouse fgf23 elisa kit picokine  (Boster Bio)
N/A
Mouse FGF23 ELISA Kit PicoKine® (96 Tests). Quantitate Mouse Fgf23 in cell culture supernatants, cell lysates, serum and plasma (heparin, EDTA). Sensitivity: 10pg/ml. The brand Picokine indicates this is a premium quality ELISA kit. Each
   Buy from Supplier
mouse fgf23 elisa kit  (OriGene)
N/A
For quantitative detection of mouse FGF23 in cell culture supernates cell lysates serum and plasma heparin EDTA
   Buy from Supplier
mouse fgf23 fibroblast growth factor 23 elisa kit  (Elabscience)
N/A
   Buy from Supplier
uncoated mouse fgf23 (fibroblast growth factor 23) elisa kit  (Elabscience Biotechnology)
N/A
   Buy from Supplier

Image Search Results


Transcriptomic analysis of femoral tissues from sham, OVX, and OVX + GLP-2 groups. A Scatter plot of DEGs between the OVX and sham groups (1654 upregulated genes and 2038 downregulated genes). B Scatter plot of DEGs between the OVX + GLP-2 and OVX groups (318 upregulated genes and 396 downregulated genes). C Heatmap of 24 representative DEGs among the three groups. D GO enrichmentresults showing DEGs involved in cellular component, biological process, and molecular function categories. E KEGG signalling pathway diagram. F KEGG enrichment bar chart. G KEGG enrichment scatter plot. H Relative mRNA expression of FGF23, FGF6, and FGF18 in the tibiae of the OVX group

Journal: Journal of Orthopaedic Surgery and Research

Article Title: GLP-2 alleviates postmenopausal osteoporosis by acting on osteoblasts through the PI3K/AKT/FOXO1 signalling pathway to downregulate FGF23 expression

doi: 10.1186/s13018-026-06661-2

Figure Lengend Snippet: Transcriptomic analysis of femoral tissues from sham, OVX, and OVX + GLP-2 groups. A Scatter plot of DEGs between the OVX and sham groups (1654 upregulated genes and 2038 downregulated genes). B Scatter plot of DEGs between the OVX + GLP-2 and OVX groups (318 upregulated genes and 396 downregulated genes). C Heatmap of 24 representative DEGs among the three groups. D GO enrichmentresults showing DEGs involved in cellular component, biological process, and molecular function categories. E KEGG signalling pathway diagram. F KEGG enrichment bar chart. G KEGG enrichment scatter plot. H Relative mRNA expression of FGF23, FGF6, and FGF18 in the tibiae of the OVX group

Article Snippet: FGF23 levels in cell culture supernatants were measured using a mouse FGF23 ELISA Kit (CSB-EL008629MO, Cusabio) following the manufacturer’s protocol.

Techniques: Expressing

Effects of GLP-2 and the PI3K inhibitor LY294002 on FGF23 expression in OVX mice. Forty-four female C57BL/6J mice were randomly divided into five groups: sham-operated (sham, n = 6), OVX treated with vehicle (OVX, n = 8), OVX treated with GLP-2 (OVX + GLP-2, n = 10), OVX treated with LY294002 (OVX + LY294002, n = 10), and OVX treated with GLP-2 plus LY294002 (OVX + GLP-2 + LY294002, n = 10). A IHC staining of FGF23 in the distal femur and corresponding MOD analysis. B Relative mRNA expression of FGF23 in femurs. C Serum FGF23 levels measured by ELISA. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001

Journal: Journal of Orthopaedic Surgery and Research

Article Title: GLP-2 alleviates postmenopausal osteoporosis by acting on osteoblasts through the PI3K/AKT/FOXO1 signalling pathway to downregulate FGF23 expression

doi: 10.1186/s13018-026-06661-2

Figure Lengend Snippet: Effects of GLP-2 and the PI3K inhibitor LY294002 on FGF23 expression in OVX mice. Forty-four female C57BL/6J mice were randomly divided into five groups: sham-operated (sham, n = 6), OVX treated with vehicle (OVX, n = 8), OVX treated with GLP-2 (OVX + GLP-2, n = 10), OVX treated with LY294002 (OVX + LY294002, n = 10), and OVX treated with GLP-2 plus LY294002 (OVX + GLP-2 + LY294002, n = 10). A IHC staining of FGF23 in the distal femur and corresponding MOD analysis. B Relative mRNA expression of FGF23 in femurs. C Serum FGF23 levels measured by ELISA. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001

Article Snippet: FGF23 levels in cell culture supernatants were measured using a mouse FGF23 ELISA Kit (CSB-EL008629MO, Cusabio) following the manufacturer’s protocol.

Techniques: Expressing, Immunohistochemistry, Enzyme-linked Immunosorbent Assay

GLP-2 downregulates FGF23 expression by activating GLP-2R/PI3K/AKT signalling in osteoblasts. A Western blot analysis of AKT and p-AKT levels in osteoblasts with or without shRNA-GLP-2R interference. B Relative mRNA expression of FGF23 in osteoblasts treated with or without shRNA-GLP-2R. C Western blot analysis of AKT and p-AKT levels in cells treated with or without LY294002. D Relative mRNA expression of FGF23 following LY294002 intervention. E Western blot analysis of AKT and p-AKT levels in cells treated with or without MK-2206. F Relative mRNA expression of FGF23 after MK-2206 treatment. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001

Journal: Journal of Orthopaedic Surgery and Research

Article Title: GLP-2 alleviates postmenopausal osteoporosis by acting on osteoblasts through the PI3K/AKT/FOXO1 signalling pathway to downregulate FGF23 expression

doi: 10.1186/s13018-026-06661-2

Figure Lengend Snippet: GLP-2 downregulates FGF23 expression by activating GLP-2R/PI3K/AKT signalling in osteoblasts. A Western blot analysis of AKT and p-AKT levels in osteoblasts with or without shRNA-GLP-2R interference. B Relative mRNA expression of FGF23 in osteoblasts treated with or without shRNA-GLP-2R. C Western blot analysis of AKT and p-AKT levels in cells treated with or without LY294002. D Relative mRNA expression of FGF23 following LY294002 intervention. E Western blot analysis of AKT and p-AKT levels in cells treated with or without MK-2206. F Relative mRNA expression of FGF23 after MK-2206 treatment. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001

Article Snippet: FGF23 levels in cell culture supernatants were measured using a mouse FGF23 ELISA Kit (CSB-EL008629MO, Cusabio) following the manufacturer’s protocol.

Techniques: Expressing, Western Blot, shRNA

GLP-2 regulates FGF23 expression via the inactivation of FOXO1. A Western blot analysis of FOXO1 and p-FOXO1 levels in osteoblasts treated with or without GLP-2. B Immunofluorescence staining of FOXO1 in osteoblasts (green), counterstained with DAPI (blue). C Relative mRNA expression of FGF23 in osteoblasts treated with the FOXO1 inhibitor AS1842856. D Verification of FOXO1 overexpression by Western blot after PCDH-FOXO1 transfection. E Effect of FOXO1 overexpression on FGF23 mRNA levels in osteoblasts with or without GLP-2 treatment. F Effect of FOXO1 overexpression on the FGF23 concentration in the cell culture supernatant. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001

Journal: Journal of Orthopaedic Surgery and Research

Article Title: GLP-2 alleviates postmenopausal osteoporosis by acting on osteoblasts through the PI3K/AKT/FOXO1 signalling pathway to downregulate FGF23 expression

doi: 10.1186/s13018-026-06661-2

Figure Lengend Snippet: GLP-2 regulates FGF23 expression via the inactivation of FOXO1. A Western blot analysis of FOXO1 and p-FOXO1 levels in osteoblasts treated with or without GLP-2. B Immunofluorescence staining of FOXO1 in osteoblasts (green), counterstained with DAPI (blue). C Relative mRNA expression of FGF23 in osteoblasts treated with the FOXO1 inhibitor AS1842856. D Verification of FOXO1 overexpression by Western blot after PCDH-FOXO1 transfection. E Effect of FOXO1 overexpression on FGF23 mRNA levels in osteoblasts with or without GLP-2 treatment. F Effect of FOXO1 overexpression on the FGF23 concentration in the cell culture supernatant. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001

Article Snippet: FGF23 levels in cell culture supernatants were measured using a mouse FGF23 ELISA Kit (CSB-EL008629MO, Cusabio) following the manufacturer’s protocol.

Techniques: Expressing, Western Blot, Immunofluorescence, Staining, Over Expression, Transfection, Concentration Assay, Cell Culture

Mechanistic diagram illustrating how GLP-2 downregulates FGF23 to ameliorate postmenopausal osteoporosis via the GLP-2R/PI3K/AKT/FOXO1 signalling pathway

Journal: Journal of Orthopaedic Surgery and Research

Article Title: GLP-2 alleviates postmenopausal osteoporosis by acting on osteoblasts through the PI3K/AKT/FOXO1 signalling pathway to downregulate FGF23 expression

doi: 10.1186/s13018-026-06661-2

Figure Lengend Snippet: Mechanistic diagram illustrating how GLP-2 downregulates FGF23 to ameliorate postmenopausal osteoporosis via the GLP-2R/PI3K/AKT/FOXO1 signalling pathway

Article Snippet: FGF23 levels in cell culture supernatants were measured using a mouse FGF23 ELISA Kit (CSB-EL008629MO, Cusabio) following the manufacturer’s protocol.

Techniques:

Figure 1. Fucoidan Treatment Reversed the Changes of Serum Biochemical Indexes Caused by the Modeling. A–D, the Levels of BUN, Creatinine, ALP, and Pi in the Serum of Mice in the Five Groups were Detected by an Automatic Biochemical Analyzer. E–G, the Levels of iPTH, FGF23, and 1,25 (OH)2D3 in the Serum of Mice in the Five Groups Were Determined by ELISA. H, the Relative BMD of Mice in the Five Groups Was Measured by X-Ray Densitometers.

Journal: Pharmacognosy Magazine

Article Title: Fucoidan Attenuated Kidney and Bone Damage Caused by CKD-MBD in Mice by Upregulating Klotho

doi: 10.1177/09731296231172549

Figure Lengend Snippet: Figure 1. Fucoidan Treatment Reversed the Changes of Serum Biochemical Indexes Caused by the Modeling. A–D, the Levels of BUN, Creatinine, ALP, and Pi in the Serum of Mice in the Five Groups were Detected by an Automatic Biochemical Analyzer. E–G, the Levels of iPTH, FGF23, and 1,25 (OH)2D3 in the Serum of Mice in the Five Groups Were Determined by ELISA. H, the Relative BMD of Mice in the Five Groups Was Measured by X-Ray Densitometers.

Article Snippet: Enzyme-linked Immunosorbent Assay (ELISA) The contents of intact parathyroid hormone (iPTH), fibroblast growth factor 23 (FGF23), and 1,25-dihydroxyvitamin D3 (1,25(OH)2D3, DHVD3) in the serum were measured by the Mouse iPTH ELISA Kit (E-EL-M0709, Elabscience, China), Mouse FGF23 ELISA Kit (E-EL-M2415C, Elabscience, China), and Mouse DHVD3 ELISA Kit (E-EL-0016C, Elabscience, China), respectively.

Techniques: Enzyme-linked Immunosorbent Assay